Euphora™ EUP2530XRecalls & reported problems
Medtronic, Inc. · BALLOON EUP2530X EUPHORA RX US · Class 2
1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 2
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00643169560055), received between May 10, 2019 and Jun 1, 2023 — classified as 1 injury, 1 malfunction.
The most frequently reported specific device problem is “Burst Container or Vessel” (1 report).
2 FDA recall records name this device's identifier, 1 still open.
1 other recall cover devices cleared under the same FDA submission (K143480); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Recalls naming this device
- Sep 3, 2019Open, Classified
Medtronic has determined that some catheters have a slightly higher diameter stylette causing removal difficulties.
Z-0122-2020 · Root cause: Under Investigation by firm · FDA record ↗
- Jul 13, 2017Terminated
Stylette removal difficulties on the Euphora and Solarice products.
Z-3136-2017 · Root cause: Process design · FDA record ↗
Most reported problems
Device problems
- Burst Container or Vessel1
- Detachment of Device or Device Component1
- Device Dislodged or Dislocated1
- Leak/Splash1
Patient problems
- Device Embedded In Tissue or Plaque1
- Insufficient Information1
- No Consequences Or Impact To Patient1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryJun 1, 2023Burst Container or Vessel; Detachment of Device or Device Component; Device Dislodged or Dislocated; Burst Container or Vessel; Detachment of Device or Device Component; Device Dislodged or Dislocated
AN ATTEMPT WAS MADE TO USE ONE EUPHORA RX PTCA BALLOON CATHETER TO TREAT A MILDLY TORTUOUS, SEVERELY CALCIFIED LESION WITH 95% STENOSIS LOCATED IN THE MID LEFT ANTERIOR DESCENDING (LAD) ARTERY. THE DEVICE WAS INSPECTED WITH NO ISSUES NOTED. NEGATIVE PREP WAS PERFORMED WITH NO ISSUES NOTED. THE LESION WAS PRE-DILATED. THE DEVICE DID NOT PASS THROUGH A PREVIOUSLY DEPLOYED STENT. RESISTANCE WAS NOT ENCOUNTERED WHEN ADVANCING THE DEVICE. EXCESSIVE FORCE WAS NOT USED DURING DELIVERY. THE DEVICE WAS NOT KINKED AND RE-STRAIGHTENED DURING USE. IT WAS REPORTED THAT A BALLOON BURST OCCURRED DURING THE SECOND INFLATION AT 15 ATM. IT WAS DETAILED THAT PART OF THE BALLOON AND MARKER-BAND DETACHED FROM THE BALLOON SHAFT AND REMAINED IN THE TARGET VESSEL. THE DETACHED PORTION OF THE BALLOON WAS REMOVED USING A TELESCOPE AND ONE 1.5X15MM EUPHORA BALLOON. THE DISTAL BALLOON MARKER WAS INITIALLY REMOVED BUT IT BECAME LOOSE AFTER REMOVING THE TELESCOPE AND FRACTURED BALLOON THE BALLOON MARKER WAS INJECTED BACK INTO A SMALL PROXIMAL SIDE BRANCH OF THE CIRCUM FLEX USING A CONTRAST INJECTION. IT WAS DECIDED TO LEAVE THE BALLOON MARKER IN THE SIDE BRANCH AS THERE WAS NO SAFE WAY TO REMOVE IT FROM THE VES
Patient problems: Device Embedded In Tissue or Plaque; Insufficient Information
MAUDE report 17036495 ↗MalfunctionMay 10, 2019Leak/Splash; Leak/Splash
DURING A PROCEDURE, AN ATTEMPT WAS MADE TO USE AN EUPHORA RX PTCA BALLOON CATHETER TO TREAT A MILDLY TORTUOUS AND CALCIFIED LESION EXHIBITING 80% STENOSIS LOCATED IN THE MID LEFT ANTERIOR DESCENDING ARTERY (LAD). THE DEVICE WAS INSPECTED WITH NO ISSUES NOTED. NEGATIVE PREP WAS PERFORMED WITHOUT ISSUE. THE LESION WAS PRE-DILATED. THE DEVICE DID NOT PASS THROUGH A PREVIOUSLY DEPLOYED STENT. RESISTANCE WAS NOT ENCOUNTERED WHEN ADVANCING THE DEVICE. EXCESSIVE FORCE WAS NOT USED DURING DELIVERY. IT WAS REPORTED THAT FOLLOWING INFLATION OF THE BALLOON AT 10ATM THAT THE BALLOON LOST PRESSURE SLOWLY. WHEN INSPECTED OUTSIDE THE BODY A SMALL PIN HOLE WAS OBSERVED. THE PATIENT WAS REPORTED TO BE ALIVE WITH NO INJURY.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8599115 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K143480. One submission often covers many models, so check the product and lot details in each record.
- Z-3137-2017 · Jul 13, 2017 · TerminatedSolarice Rapid Exchange Balloon Dilatation Catheter, a Percutaneous Transluminal Coronary Angioplasty (PTCA) Rapid Exchange System.
Other Catheters, transluminal coronary angioplasty, percutaneous devices
- MINI TREK™ 1012270-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous223 reports
- Maverick²™ H7493892815200Boston Scientific Corporation · Catheters, transluminal coronary angioplasty, percutaneous1 death203 reports
- MINI TREK™ 1012270-12Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous162 reports
- Maverick²™ H7493892820200Boston Scientific Corporation · Catheters, transluminal coronary angioplasty, percutaneous161 reports
- NC TREK 1012454-08Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous2 recalls59 reports
- TREK™ 1012272-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous2 deaths158 reports
- NC TREK 1012453-12Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous1 recall84 reports
- NC TREK 1012453-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous1 recall1 death83 reports
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.